These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 4030101)

  • 21. Accurate prediction of anti-phagocytic activity of Vibrio vulnificus by measurement of bacterial adherence to hydrocarbonsPrediction of Anti-Phagocytic Activity.
    Kado T; Kashimoto T; Yamazaki K; Matsuda K; Ueno S
    APMIS; 2019 Feb; 127(2):80-86. PubMed ID: 30575139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differing resistance to polymorphonuclear cells of halophilic- and hypotonic-types of Vibrio vulnificus.
    Tsuru S; Taniguchi M; Fujisawa H; Zinnaka Y; Nomoto K
    J Clin Lab Immunol; 1987 Apr; 22(4):185-9. PubMed ID: 3612754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of opsonization on oxidative metabolism of plaice (Pleuronectes platessa L.) neutrophils.
    Nash KA; Fletcher TC; Thomson AW
    Comp Biochem Physiol B; 1987; 86(1):31-6. PubMed ID: 3829631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies that react with the capsular polysaccharide of Vibrio vulnificus are detectable in infected patients, and in persons without known exposure to the organism.
    Fiore A; Hayat U; Wasserman SS; Wright A; Bush CA; Morris JG
    Diagn Microbiol Infect Dis; 1996 Mar; 24(3):165-7. PubMed ID: 8724403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vibrio vulnificus damages macrophages during the early phase of infection.
    Tsuchiya T; Mitsuo E; Hayashi N; Hikita Y; Nakao H; Yamamoto S; Miyamoto K; Tsujibo H
    Infect Immun; 2007 Sep; 75(9):4592-6. PubMed ID: 17591793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients' sera.
    Shin SH; Shin DH; Ryu PY; Chung SS; Rhee JH
    FEMS Immunol Med Microbiol; 2002 Jun; 33(2):133-8. PubMed ID: 12052568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse skin damage caused by cytolysin from Vibrio vulnificus and by V. vulnificus infection.
    Gray LD; Kreger AS
    J Infect Dis; 1987 Feb; 155(2):236-41. PubMed ID: 3805762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential properties of organ-specific serum opsonins for liver and spleen macrophages.
    Moghimi SM; Patel HM
    Biochim Biophys Acta; 1989 Sep; 984(3):379-83. PubMed ID: 2775783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of TSC1 in the Macrophages Against
    Huang XH; Ma Y; Lou H; Chen N; Zhang T; Wu LY; Chen YJ; Zheng MM; Lou YL; Xie DL
    Front Cell Infect Microbiol; 2020; 10():596609. PubMed ID: 33585271
    [No Abstract]   [Full Text] [Related]  

  • 30. Capsular polysaccharide-protein conjugate vaccines of carbotype 1 Vibrio vulnificus: construction, immunogenicity, and protective efficacy in a murine model.
    Devi SJ; Hayat U; Frasch CE; Kreger AS; Morris JG
    Infect Immun; 1995 Aug; 63(8):2906-11. PubMed ID: 7622211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface phagocytosis of Staphylococcus epidermidis and Escherichia coli by human neutrophils: serum requirements for opsonization and chemiluminescence.
    Gordon DL; Avery VM; Rice JL; McDonald PJ
    FEMS Microbiol Immunol; 1989 Dec; 1(8-9):417-23. PubMed ID: 2697319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmented uptake of neuraminidase-treated sheep red blood cells: participation of opsonic factors.
    Schmidtke JR; Simmons RL
    J Natl Cancer Inst; 1975 Jun; 54(6):1379-84. PubMed ID: 48553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phagocytosis imprints heterogeneity in tissue-resident macrophages.
    A-Gonzalez N; Quintana JA; García-Silva S; Mazariegos M; González de la Aleja A; Nicolás-Ávila JA; Walter W; Adrover JM; Crainiciuc G; Kuchroo VK; Rothlin CV; Peinado H; Castrillo A; Ricote M; Hidalgo A
    J Exp Med; 2017 May; 214(5):1281-1296. PubMed ID: 28432199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into the antibacterial and immunomodulatory functions of tilapia hepcidin (TH)2-3 against Vibrio vulnificus infection in mice.
    Pan CY; Lee SC; Rajanbabu V; Lin CH; Chen JY
    Dev Comp Immunol; 2012 Jan; 36(1):166-73. PubMed ID: 21756935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vibrio vulnificus VvhA induces Th1 and Tfh cells to proliferate against Vibrio vulnificus in a mouse model of infection.
    Wang MY; Liu XF; Xia J; Li Y; Geng JL; Hu CJ
    Future Microbiol; 2017 Sep; 12():953-965. PubMed ID: 28816516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Vibrio vulnificus by indirect immunofluorescence.
    Gray LD; Kreger AS
    Diagn Microbiol Infect Dis; 1985 Nov; 3(6):461-8. PubMed ID: 3905226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A recombinant metalloprotease antigen of Vibrio vulnificus elicits protective antibodies in a murine model.
    Chen YC; Chang CC; Chang SY; Su JH
    Lett Appl Microbiol; 2010 Feb; 50(2):168-72. PubMed ID: 20002577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors in human serum promoting phagocytosis of Pseudomonas aeruginosa. II. Interaction of opsonins with the phagocytic cell.
    Bjornson AB; Michael JG
    J Infect Dis; 1974 Nov; 130 Suppl(0):S127-31. PubMed ID: 4214224
    [No Abstract]   [Full Text] [Related]  

  • 39. Passive protective effect of chicken egg yolk immunoglobulins against experimental Vibrio anguillarum infection in ayu (Plecoglossus altivelis).
    Li CH; Lu XJ; Li DF; Chen J
    Fish Shellfish Immunol; 2014 Mar; 37(1):108-14. PubMed ID: 24486630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemolymph C1qDC promotes the phagocytosis of oyster Crassostrea gigas hemocytes by interacting with the membrane receptor β-integrin.
    Lv Z; Wang L; Jia Z; Sun J; Wang W; Liu Z; Qiu L; Wang M; Song L
    Dev Comp Immunol; 2019 Sep; 98():42-53. PubMed ID: 30995452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.